Ark Clinical Research — Long Beach, California

Public research footprint of Ark Clinical Research, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Overweight · Diabetes Mellitus, Type 2 · Metabolic Dysfunction Associated Steatohepatitis (MASH) · Atherosclerotic Cardiovascular Disease (ASCVD)

Recently updated registry entries

NCT07064473 — EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… (Recruiting)
NCT07575932 — A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) (Recruiting)
NCT07351058 — A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ark Clinical Research?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.